Beneath is a calmly edited, AI-generated transcript of the “First Opinion Podcast” interview with Thomas Goetz. Be certain to enroll in the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about every new episode by signing up for the “First Opinion Podcast” e-newsletter. And don’t overlook to enroll in the First Opinion e-newsletter, delivered each Sunday.
Torie Bosch: Whether or not it’s Ambien or Wegovy, ivermectin or fluoride, each drug in your medication cupboard or marketed on TV has a narrative behind it. Not simply the way it got here to be, however the way it finally ends up affecting society in sudden methods, large or small.
Welcome to the “First Opinion Podcast.” I’m Torie Bosch, editor of First Opinion. First Opinion is STAT’s house for large, daring concepts from well being care suppliers, researchers, sufferers, and others who’ve one thing to say about medication’s most vital and attention-grabbing matters. This season, we’re targeted on the intersection of drugs and tradition.
And as we speak I’m talking with Thomas Goetz. He’s a journalist, an entrepreneur, and the host of the brand new podcast “Drug Story.” After a fast break, I’ll carry you our dialog about public well being, parasites, and Huge Pharma.
Thomas Goetz, welcome to the “First Opinion Podcast.”
Thomas Goetz: Thanks for having me, Torie.
Bosch: So congratulations in your new podcast. For anybody who has sadly not listened to it but, are you able to inform us a bit bit in regards to the premise?
Goetz: Positive. Properly, simply what the world wants, one other podcast. However I had this concept that I couldn’t shake, which was that there’s an entire world of well being and medication behind the medicine we take. That in each drug, each medicine, that there’s a a lot bigger story to inform about well being and medication and society and enterprise and economics. This concept of utilizing one drug at a time to inform bigger tales about illness and well being in society, and the way we obtained there — how these ailments emerged, how we acknowledged them, how we identified them — it simply turned, to me, a really highly effective approach to assist individuals perceive each the promise of drugs and medicines, but in addition the restrictions of drugs, medicines, to unravel what can typically be bigger social issues.
And so that’s what I attempt to do. And each episode is a special drug, and that allows you to get into all kinds of various issues, from melancholy to weight problems to autoimmune issues, no matter it’s. As I all the time say, there are a number of medicine on the market. And so there’s a close to infinite approach of telling the story of human civilization by way of the prism of medicine.
Bosch: Yeah, and also you kind of format or construction every episode on this actually neat approach. Are you able to inform us a bit bit in regards to the three components?
Goetz: I used to be pondering, OK, nicely, if I wish to inform the story of a illness and ailments and coverings, how do you construction it? So I stole a web page from one of the best, which on this case is “This American Life,” which all the time does, you already know, each episode in a sequence of acts. Being a English main, I used to be drawn to the concept of construction.
And so I got here up with these three — it’s not sensible, it’s fairly apparent — there’s the prognosis, the prescription, after which uncomfortable side effects. So the prognosis is a strategy to clarify the illness, what’s the precise illness in play and the way did that emerge through the years? The prescription is in regards to the drug, the place we truly speak about how the illness is handled largely by way of the one drug. After which uncomfortable side effects is just not a lot the quick so-called hostile results or hostile occasions of the drug itself a lot because the bigger social penalties or contextual penalties of utilizing X drug on Y illness. And so uncomfortable side effects, principally it’s a rhetorical machine or a story machine, this 3X construction, that lets me go numerous totally different locations. It lets me to go to historical Babylonia or to the halls of Congress or to inside advertising and marketing departments at pharma firms. Nevertheless it’s sufficient of a construction to type of inform the story. And it turned out that it’s a helpful machine.
Do Individuals anticipate an excessive amount of from medicine?
Bosch: Yeah, I’ve to admit that on the current ivermectin episode, I didn’t make it previous the prognosis. It was a bit onerous to take heed to the tales of parasites.
Goetz: Oh, nicely, so the parasites, I imply, ivermectin, that was an ideal instance of what the illness, the illness that the drug was initially created or found to work on, which is parasitic infections. In that concept of prescription, hastily the concept got here, nicely, can we repurpose the drug? Which is a superb concept, an ideal use of pharmaceutical medicine. Some repurposing has opened the door to all kinds of recent makes use of and new therapies and new assist for individuals. However within the case of ivermectin, it’s, in some ways, the hope for repurposing reasonably than the precise impact of repurposing, at the least to this point, by way of Covid and perhaps even most cancers.
Bosch: I’ll return [and listen to] to the uncomfortable side effects. For positive. I simply … the half the place you’re speaking a couple of parasite whose title escapes me largely as a result of I don’t wish to have nightmares about it — a parasite that changed its host’s tongue after which begins to reside as a tongue in its host.
Goetz: Yeah. Oh, yeah. Properly, it’s a fish, to be clear. It’s not a human. That’s not a human parasite.
Bosch: Nonetheless.
Goetz: Yeah, that’s my favourite parasite as a result of it’s the nightmare situation of what a parasite might do and, and does, and yeah, it eats the tongue after which takes the place proper within the mouth, proper contained in the fish’s mouth. and does all of the work {that a} tongue does, however, takes a bit off the highest for itself.
Bosch: Want to hook up with Disney in regards to the subsequent “Discovering Nemo” film. It looks as if an ideal premise to me. In order a lot as I might maintain speaking about that …
So you latterly, alongside the debut of “Drug Story,” which we should always say simply began in January, is that proper, January? So alongside the debut of the present again in January, you wrote a very compelling essay for First Opinion and STAT about how Individuals anticipate an excessive amount of from medicine. So I’m wondering when you might elaborate on that a bit bit and the way that concept may animate your strategy to the present.
Goetz: Proper, so I used to be glad for the chance to jot down this as a result of that is an concept that had been bouncing round my head for years, actually. It begins from the attitude of the affected person once they go into the physician’s workplace with a priority and oftentimes get a prognosis and get a prescription. And so many instances the affected person leaves with that prescription, I’m pretending I’m holding a bit of paper however it’s most likely on their telephone. They usually suppose it’s gonna remedy their issues, proper? The expectations, the hope is so excessive for that prescription to be the salve for his or her ills.
However in actuality, it doesn’t work that approach. It oftentimes is just not the answer. Oftentimes it’s that prescription is simply step one on this sequence of trial and error and changes and titration and different drugs that they need to attempt. The prescription is never the answer. And actually, the prescription can create its personal physique of complexity and uncomfortable side effects, not simply within the physique, however by way of, you already know, are you able to afford the drug? Is it one thing that works with the opposite drugs you’re presupposed to be taking, and many others., and many others.? So it’s step one into one other world of complexity.
I used to be actually interested in this stress between what oftentimes is the hope. I imply, it’s truly nice. The examples, one of the best instance is, you already know, the [direct-to-consumer] drug commercials which are allowed. They type of are available two components. The primary half is the darkish clouds parting and the solar shining by way of and the affected person, the individuals have a brand new world of alternative and promise and well being, after which comes the second half of the drug. The place it’s the very quick, speaking about all these uncomfortable side effects and all these issues and penalties that weren’t meant.
And in order that duality between what we wish out of the drug and what the fact is, I feel is one thing that, we as a society simply are so hopeful and so … so desirous of a optimistic end result, however it’s much more sophisticated than that. And in order that was actually what I used to be making an attempt to get at. And I feel that goes again all the way in which to, I imply, I consider “Romeo and Juliet,” when on the finish of “Romeo and Juliet,” Romeo goes to the apothecary to get the drug that may put Juliet right into a deep trance for a pair days in order that they will escape collectively and run away and reside their life fortunately ever after. Properly, it doesn’t work that approach, proper? “Romeo and Juliet” is a tragedy. The drug doesn’t work, however they need it to be a magic potion. And, nicely, truly it does work.
Bosch: The drug kind of does work, although, proper, and it’s simply not used as directed?
Goetz: Sure, precisely, not used, as directed, and Romeo jumps the gun pondering that she’s truly died, and many others., and many others. However yeah, so the disconnect between our hopes and the fact is basically what I used to be making an attempt to get at.
Bosch: And so the present actually captures that as nicely. You already know, I’m fascinated with the current episode on Ambien, which started with a very fascinating kind of historic have a look at insomnia as a contemporary creation. And it does appear that you just appear to be targeted at the least initially on these medicine that basically intersect with the ails of contemporary life, proper? So insomnia, weight problems, dependancy. Is that kind of a particular space of curiosity to you?
Goetz: Properly, I’m a public well being man, so these are all type of what are sometimes known as the social determinants of illness or typically the industrial determinants of illness. So I’m very interested by these areas. I’m additionally interested by the way in which they’ve been described as mismatched ailments the place our our bodies have been developed to do X, Y, or Z after which the world we constructed is just not is just not the world that our our bodies have been developed to inhabit. After which you’ve got industrial forces just like the meals business or the electronics business, forcing different issues into the equation that type of make issues very sophisticated.
And so we’re principally not utilizing our physique as directed, if you’ll. And so then we give you medicine like Ambien, which may be very efficient, but in addition can, you already know, teasing out the impact from a number of the penalties may be actually difficult. So I feel I’ve all the time been on this concept of, how deeply does the issue go? How deeply does the illness go by way of going again and again and again?
Weight problems is a superb instance. It’s not only a downside with hyper-, ultra-processed meals, however it’s additionally an issue with the cheapness and ubiquity of grain. One of many best innovations within the final 100 years was scientific industrial agriculture allowed [us] to feed billions of individuals, however it additionally made grain actually low cost and in order that, you already know, you may comply with the trajectory. So I feel that’s considered one of enjoyable — nicely, I say enjoyable. To me, it’s a compelling story that hopefully helps the listeners of the podcast perceive their world a bit higher and perceive how we obtained to the illness in query a bit extra completely.
Bosch: And so, you already know, for years earlier than the podcast, you have been a reporter reporting largely on well being, is that proper?
Goetz: Yeah, I used to be expertise and a enterprise journalist. Then I used to be govt editor at Wired, after which I obtained my [master’s of public health] at Berkeley as a result of I noticed across the nook to the way forward for journalism, and it didn’t look shiny. And so I figured, OK, I higher get a bit extra experience below my noggin. In order that was public well being.
Bosch: I’ve positively appeared on the MPH program at Johns Hopkins late at night time imagining what my future may seem like. So I determine with that.
How do you suppose having an MPH has modified your strategy to journalism?
Goetz: Oh, nicely, I imply, it finally reworked my profession. I’m very eager to grasp programs and constructions and contexts. That to me is like, if you can also make these invisible constructions seen, it helps me perceive the world and hopefully it’ll assist individuals perceive the phrase. And in order that’s what public well being is in some ways. It’s understanding the context of illness, the opposite forces past the well being care system that manifest in illness or well being or sickness. After which simply fascinated with the way you make sense of that mess. So epidemiology as a science is making an attempt to show the cacophony of on a regular basis life into one thing which you can parse it sufficient to grasp perhaps causation. These guidelines and rule units, I feel, have been very highly effective to me in telling tales that assist individuals make sense of their lives, make sense of the challenges they face by way of their well being selections, their medical choices, and so forth. To me, these are considerations and points which are as distinguished as local weather change for contemporary society, like these are the good alternatives, but in addition the, perhaps our largest, a few of our largest issues.
Bosch: Ought to extra journalists be getting masters of public well being?
Goetz: Properly, I encourage everybody to get a grasp’s in public well being, particularly M.D.s, you already know, the M.D.s who I do know, together with my very own sister, who’ve gone forward and gotten the MPH, it type of opens dimensions, multidimensional universes by which you don’t simply take into consideration one affected person, you concentrate on complete populations of sufferers, or higher but, not simply sufferers however individuals. I really feel prefer it’s an extremely highly effective diploma and a really highly effective type of body of reference. For journalists, I feel it’s highly effective as a result of public well being is so many various issues. It’s the whole lot from well being care, well being care administration, hospital programs, economics to biotechnology, epidemiology. It will get sophisticated quick.
However I discover that for anyone who’s contemplating it, I all the time am like, yeah, go forward. Tried to do it as quick as potential. And I imply, I used to be very fortunate. This system I used to be in was the interdisciplinary MPH at Berkeley, which meant you took a bit little bit of the whole lot throughout the general public well being menu. And that was very useful to me as a journalist, simply so I’ve a passing potential to grasp or to start out to consider a few of these deeper questions like infectious illness, proper? Like that’s one other space the place it seems that it issues. It’s good to know a bit bit about one thing about infectious illness as of late.
Bosch: For positive. So forward of our dialog, I used to be trying by way of your previous writer web page on Wired. And I feel that is from while you have been govt editor. I used to be actually struck by a function from [2006] titled “The Skinny Tablet: 75 million Individuals could have one thing known as metabolic syndrome. How Huge Pharma turned weight problems right into a illness — then invented the medicine to remedy it.” Do you keep in mind writing that story very clearly?
Goetz: Oh yeah, I overlook the title of the drug, however it was in some ways the precedent for GLP-1s. And at the moment it was, you already know, that was seven years earlier than the American Medical Affiliation acknowledged weight problems as a illness. And it was additionally this concept that medication as a therapy for weight problems had a number of promise, however it additionally can be a really elementary shift in how society considered this situation and the way we will use or may use medicines to deal with it. I’ve to learn that once more. I most likely was extra skeptical of the concept of utilizing medicine to deal with it than I might be as we speak. However I feel it was an instance of type of making an attempt to make use of this lens of sufficient public well being to consider medication. So yeah, it’s an previous noticed I’ve been sawing at for some time, I suppose.
Bosch: Yeah, I imply, so I discovered it tremendous attention-grabbing to learn. I vaguely keep in mind studying it on the time, I wish to say. And I feel I used to be simply kind of attention-grabbing, evaluating it to your protection of Wegovy, which I feel talked in considerably related phrases in regards to the concept of weight problems as a illness and a tablet to remedy it. And as you say, with the Wired piece from [2006], you probably did appear a lot extra skeptical than in discussing it, albeit with, after all, numerous nuance on “Drug Story.” So I used to be questioning when you might perhaps speak a bit bit about your fascinated with the subject and the way that’s modified as kind of indicated by your writing about it.
Goetz: One of many issues that I’ve actually come to understand within the final, since I obtained my MPH, since 2007, say, the final 20 years of overlaying well being and digital well being and medication and expertise is how a lot of well being is that this stress that’s truly a really elementary American stress between private duty and a typical good or a better good. And in some ways, the type of difficulty of weight problems is a superb instance of that stress. So there’s a number of emphasis on private duty, free will, private selection, on the subject of what we eat, proper? And the concept that weight-reduction plan and train are as much as you. And I feel that’s true to some extent. We do have decisions there.
However there are additionally better constructions and programs at work that, I feel, 20 years in the past, I used to be not giving sufficient heed or paying sufficient credit score to the concept of a typical good. The concept that there are these bigger programs which are typically being manipulated by industrial pursuits just like the meals business and manipulated on a person foundation. It’s principally benefiting from our potential to make decisions, to principally entice us to make what grow to be unhealthy decisions. And I feel you see that proper now rather a lot with MAHA and the emphasis on private decisions, private duty, and the actual, in some methods, the actual assault on the concept of really there’s a widespread good and there’s an obligation of presidency, of regulators, of our well being infrastructure, to guard our residents and to create some requirements of, and entry to, requirements of well being and medication. And clearly that’s all the time been, that goes again over 100 years on this nation. That’s a permanent stress in our medical care and in our nation at giant.
However I do suppose it has come out and is basically delivered to the fore within the debate round GLP-1s and weight problems. And in, you already know, my 2026 self truly believes that GLP-1s truly don’t remedy the issue. They don’t seem to be an answer to our social downside of a rise in charge of weight problems. Our social downside of unhealthy meals being so prevalent and so low cost and being sponsored by the federal government. Like, if the federal government is subsidizing agriculture, on the one hand, why will we anticipate private selection? Like, we should always have some authorities on the opposite facet, too, perhaps making an attempt to guard us from a few of these, a number of the results of these subsidies.
Anyway, I really feel prefer it’s an ideal instance of the place we really want, particularly now, this concept of a typical good and a typical well being and an expectation. All of our residents [should] be capable of reside a wholesome life. You already know, to have wholesome meals, to have wholesome water, to have protected streets. These are the essential protections of presidency. They usually have large well being implications. And there are constructions and programs that, sadly, are below assault and being questioned in ways in which they by no means had been within the final hundred years. Sorry about that rant.
Bosch: No, it was unbelievable. As a result of as you have been speaking, I used to be pondering a lot about your First Opinion essay about anticipating an excessive amount of from medicine. And in some methods, then it feels prefer it’s much less that Individuals anticipate an excessive amount of from medicine individually, although, after all, I’m positive we do. However extra that the system, as you’re discussing, expects the drug to repair the system’s issues, proper? Or the issues created by the system, proper? So the system creates the issue of weight problems after which creates a tablet to unravel it reasonably than fixing the large system.
Goetz: Yeah, which is completely true. I imply the EpiPen, the primary episode of the podcast, is a superb instance of that, proper? There was this creation of a drug supply system that, you may ship a therapy for allergy in a short time and successfully. And everybody with meals allergy symptoms now carries not only one, however two EpiPens, which is nice.
Why is there such an upsurge in meals allergy symptoms in america or in Western nations? What’s happening with the way in which we eat in our immune programs that has modified? Properly, it seems that the rules for nearly 20 years from the [American Academy of Pediatrics] have been precisely incorrect in recommending that oldsters reduce their infants’, younger infants’ publicity to doubtlessly allergic meals: peanuts, milk, eggs, what have you ever. And so these tips created, or helped create, I needs to be cautious in my phrases, helped create an epidemic of meals allergy symptoms that was pushed by human selections and by well-intentioned insurance policies that have been basically flawed, misguided understanding of what truly is going on in our immune programs, which is an extremely sophisticated system.
I feel the truth that we have now a drug now to deal with these circumstances or to deal with the anaphylactic shock or anaphylactic response, it’s great. However it’s a nice instance of how the certitude that we would have round our suggestions or tips or insurance policies in well being and medication are all the time topic to vary, are all the time topic to new science and new understanding. And medication is a science by way of the vessel of human understanding and the bounds of human understanding. You already know, that’s the enjoying discipline on which drugs will all the time be type of on the market.
Bosch: Completely. I’ve a 2-year-old, and I’ll always remember making an attempt to persuade her to drink pureed salmon when she was 7 months previous to attempt to stave off any future fish allergy symptoms on our pediatrician’s suggestion. She was not .
Goetz: That’s dedication.
Bosch: I attempted.
Goetz: Present me a 7-month-old who can be.
Bosch: Numerous them, apparently. So, as we begin to wrap up, the place is “Drug Story” heading subsequent?
Goetz: Properly, I’ve simply completed the primary season, so it was extremely gratifying. It took me a 12 months to give you 10 episodes, and I put it out not likely realizing what was gonna occur with it. And it’s been thrilling to see so many individuals reply to it. And for a short window of time, it outranked Oprah on Apple Podcasts. And I’ve a screenshot of it and the whole lot. It’ll be on my headstone.
Nevertheless it’s actually been thrilling to see that there’s an viewers for tales about not simply medicines, however the secret is, it’s actually about public well being. It’s actually these constructions and programs of the human layer and the way we how we deal with and take into consideration illness, and lots of people like these tales. In order that’s great, and I’m extremely gratified that that it has been successful. So I’m gonna do a second season, and I’ve a listing of 30 medicine.
As I all the time prefer to say, there are over 3,000 medicine behind a typical pharmacist counter. So there are a number of medicine on the market which have tales and that type of opened the door to those type of human ranges of understanding. So I’ve one other 30 that I’m gonna lower down and hopefully earlier than the tip of the 12 months, my aim is earlier than the of 2026, I’ll begin a second season. I ought to say, I’m doing this independently. I’ve no distributor or manufacturing firm. I’m on the market buying my very own present to get sponsors and help. So if I can get a few these items in place, then we’ll have one other episode or one other season by the tip of 2026. And like, I haven’t performed insulin and diabetes. I haven’t performed ADHD and Adderall. I wish to speak about Humira and autoimmune issues. I’ve this wonderful three-part miniseries on fortified meals, iodine in salt, and vitamin D in milk, and folic acid in flour. They usually’ve simply added folic acid to corn masa [in California] — I’m enthusiastic about that. So these are all wonderful tales to inform that I imagine will proceed to carry the story of well being and medication to increasingly individuals. So I’m exited about that second season.
Bosch: Properly, I can’t wait. It’s simply such a enjoyable present to take heed to, by way of bridging, as you say, the big-picture public well being with particular person tales and wild anecdotes, which all the time make for some compelling listening. So thanks a lot for the present. And thanks for approaching the “First Opinion Podcast.”
Goetz: Thanks, Torie. Thanks to STAT. I’m a loyal subscriber, and I hope to get the prospect to contribute once more.
Bosch: And thanks for listening to the “First Opinion Podcast.” It’s produced by Hyacinth Empinado. Alissa Ambrose is the senior producer, and Rick Berke is the manager producer. You may share your opinion in regards to the present by emailing me at [email protected]. And please depart a assessment or score on no matter platform you utilize to get your podcasts.
Till subsequent time, I’m Torie Bosch and please don’t maintain your opinions to your self.
